Modulating Inhibitory Control Networks in Gambling Disorder With Theta Burst Stimulation
CNS Onlus
40 participants
May 20, 2018
INTERVENTIONAL
Conditions
Summary
In this project the investigators propose a randomized double-blind placebo-controlled design in which 40 patients with GD will receive active or sham cTBS to the pre-SMA for 2 weeks. The investigators will combine TMS, multimodal structural and functional MRI and behavioral measures in order to identify circuit-level mechanisms of action and therapeutic targets (connectivity changes that explain clinical improvement) and assess the efficacy of TMS in modulating inhibitory control and symptom severity in this population.
Eligibility
Inclusion Criteria2
- DSM-5 diagnosis of Gambling Disorder
- Age between 18 and 65 years
Exclusion Criteria9
- any additional current psychiatric comorbidity, except for nicotine addiction;
- a lifetime DSM-5 diagnosis of schizophrenia or other psychotic syndromes, substance dependence or substance abuse, including alcohol, bipolar I or II disorder, mental disorder due to a general medical condition;
- serious suicide risk;
- illness duration less than two years;
- hospitalization in the last 6 months;
- the inability to receive TMS because of metallic implants, or history of seizures (personal or family history of seizure in first degree relatives);
- any major medical disease;
- pregnancy or nursing of an infant;
- the inability or refusal to provide written informed consent.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Neuromodulation tool
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03669315